R&D Pipeline

Pipeline (2021-2030)

Gastrointestinal - Preclinical (1)

Modality Indication Targets Stage Company Project No. Detail
1 Preclinical Development of a High-Performance Iron-Based MRI Contrast Agent Specialized for MR Cholangiopancreatography toward Phase 1/2a IND
Others-Synth. Magnetic resonance cholangiopancreatography (MRCP) - Preclinical Inventera Inc. RS-2025-25453205